Citigroup Inc Biond Vax Pharmaceuticals Ltd. Put Options Transaction History
Citigroup Inc
- $169 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
About BiondVax Pharmaceuticals Ltd.
- Ticker BVXV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,678,800
- Market Cap $12M
- Description
- BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...